A 54-Year-Old Woman With Donor Cell Origin of Multiple Myeloma After Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of CML

Case Reports in Hematology
doi 10.1155/2016/6751914
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

The Current Status of Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2006English

Successful Treatment of Griscelli Syndrome With Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2002English

CD34-selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed, High-Risk Multiple Myeloma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

Hematopoietic Stem Cell Transplantation for Multiple Myeloma Beyond 2010

Blood
BiochemistryImmunologyCell BiologyHematology
2010English

Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma

Seminars in Hematology
Hematology
2009English

Complete Remission of Psoriasis After Autologous Hematopoietic Stem-Cell Transplantation for Multiple Myeloma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2008English

Outcomes of Lung Transplantation After Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Patients With Multiple Myeloma Develop SOX2-Specific Autoantibodies After Allogeneic Stem Cell Transplantation

Clinical and Developmental Immunology
2011English

Allogeneic Hematopoietic Stem Cell Transplantation

Archives of Internal Medicine
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy